BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+17.29%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11B
AUM Growth
+$11B
(+16%)
Cap. Flow
+$82.4M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
83.4%
Holding
143
New
7
Increased
14
Reduced
17
Closed
6
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$63.3M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$46.5M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$41.4M |
| 4 |
Neurogene
NGNE
|
$37.2M |
| 5 |
Exelixis
EXEL
|
$30M |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$24.9M |
| 2 |
XNPT
XENOPORT, INC.
XNPT
|
$24.5M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$19.9M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$17.8M |
| 5 |
Novavax
NVAX
|
$17.3M |
Sector Composition
| 1 | Healthcare | 82.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.38B | 21.61% | 44,100,294 +861,327 | +2% | +$46.5M |
|
2
Incyte
INCY
$16.5B
| $2.22B | 20.11% | 23,498,898 +201 | +0% | +$19K |
|
3
AbbVie
ABBV
$372B
| $905M | 8.21% | 14,343,358 -30,180 | -0.2% | -$1.9M |
|
|
4
Acadia Pharmaceuticals
ACAD
$4.38B
| $821M | 7.45% | 25,819,768 +1,303,030 | +5% | +$41.4M |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $802M | 7.28% | 6,543,295 | – | – |
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $445M | 4.04% | 4,806,483 | – | – |
|
|
GHDX
7
DELISTED
Genomic Health, Inc.
GHDX
| $398M | 3.61% | 13,770,302 +101,436 | +0.7% | +$2.93M |
|
|
DBVT
8
DBV Technologies
DBVT
$264M
| $200M | 1.82% | 5,509,560 | – | – |
|
|
9
Neurogene
NGNE
$264M
| $141M | 1.28% | 10,536,092 +2,783,605 | +36% | +$37.2M |
|
|
BLCM
10
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $96.8M | 0.88% | 4,865,647 | – | – |
|
11
Cerus
CERS
$251M
| $81.1M | 0.74% | 13,053,275 -500,000 | -4% | -$3.11M |
|
|
ONCE
12
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $79.2M | 0.72% | 1,318,341 | – | – |
|
|
ACOR
13
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $76.4M | 0.69% | 3,661,082 | – | – |
|
|
AMRN
14
Amarin Corp
AMRN
$311M
| $65.8M | 0.6% | 20,630,477 +19,828,617 | +2,473% | +$63.3M |
|
|
15
Exelixis
EXEL
$10.1B
| $63M | 0.57% | 4,929,494 +2,349,494 | +91% | +$30M |
|
|
ONC
16
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $58.9M | 0.53% | 1,912,680 | – | – |
|
|
NVTA
17
DELISTED
Invitae Corporation
NVTA
| $57.4M | 0.52% | 6,554,967 | – | – |
|
18
Heron Therapeutics
HRTX
$207M
| $49.2M | 0.45% | 2,857,250 | – | – |
|
|
19
BioCryst Pharmaceuticals
BCRX
$1.74B
| $48.4M | 0.44% | 10,963,944 -4,046,590 | -27% | -$17.8M |
|
20
Neurocrine Biosciences
NBIX
$13.8B
| $45.3M | 0.41% | 895,422 | – | – |
|
|
AAAP
21
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $39.2M | 0.36% | 1,029,247 +196,158 | +24% | +$7.47M |
|
|
ARAV
22
DELISTED
Aravive, Inc. Common Stock
ARAV
| $26.1M | 0.24% | 2,134,247 -589,152 | -22% | -$7.22M |
|
|
PGNX
23
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $23.1M | 0.21% | 3,650,808 -319,442 | -8% | -$2.02M |
|
|
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $22.8M | 0.21% | 2,466,702 +225,000 | +10% | +$2.08M |
|
|
ARRY
25
DELISTED
Array Biopharma Inc
ARRY
| $22.3M | 0.2% | 3,310,666 -1,000,000 | -23% | -$6.75M |
|